August Health vs Danaher Corporation
Side-by-side comparison of AI visibility scores, market position, and capabilities
Assisted living operations and care management platform built for modern senior living communities, replacing paper-based workflows with AI-assisted assessments and digital care planning.
About
August Health is a San Francisco, California-based senior care technology company building a modern cloud-native platform for assisted living and memory care communities. Founded in 2019 and having raised over $14 million from investors including a16z and others, August Health targets the large segment of senior living communities still operating on paper-based or legacy software workflows. The company's platform digitizes resident assessments, care planning, incident reporting, medication management, and family communication in a design-forward interface built for use by care staff on mobile devices.\n\nA key differentiator for August Health is its use of AI to assist care staff in completing state-required assessments and care plans. The platform can generate draft care plan language based on assessment responses, reducing the documentation burden on caregivers while improving consistency and completeness of clinical records. This AI-assisted documentation capability is particularly valuable in assisted living, where staffing challenges and high turnover make efficient documentation workflows critical to operational quality.\n\nAugust Health competes with established vendors like Yardi Senior Living and MatrixCare but targets smaller independent communities and regional groups that find legacy platforms overly complex and expensive for their needs. The company's modern UX, mobile-first design, and AI-assisted features position it as a next-generation alternative in a market where much of the installed base runs on software designed before smartphones existed. As the senior care sector faces mounting staffing pressure, technology that reduces administrative burden on direct care staff is increasingly valued by operators.
Washington DC life sciences instruments (NYSE: DHR) at $23.9B FY2024 revenue; Cytiva bioprocessing, Beckman Coulter diagnostics, biopharma destocking recovery, 2025 core revenue +3% guidance competing with Thermo Fisher.
About
Danaher Corporation is a Washington, D.C.-based global science and technology company — publicly traded on the New York Stock Exchange (NYSE: DHR) as an S&P 500 Health Care component — developing, manufacturing, and marketing analytical instruments, reagents, consumables, software, and services for life sciences research, clinical diagnostics, and environmental monitoring through approximately 65,000 employees worldwide. In fiscal year 2024, Danaher reported revenues of $23.9 billion (flat year-over-year) with non-GAAP core revenue declining 1% as the biopharma sector's inventory destocking cycle continued, with Q4 2024 revenue of $6.5 billion (+2.0% reported, +1.0% core) representing an inflection toward recovery, generating $6.7 billion in operating cash flow and $5.3 billion in free cash flow. Danaher guided 2025 core revenue growth of approximately 3% — marking the expected return to growth as biopharma customers who destocked pandemic-era bioprocessing supply surpluses return to normalized purchasing. CEO Rainer Blair leads Danaher's post-spinoff strategy: in September 2023, Danaher separated its Environmental & Applied Solutions segment as Veralto Corporation (NYSE: VLTO), creating two independent public companies — Danaher (pure-play life sciences and diagnostics) and Veralto (water quality and product identification). Danaher's current portfolio centers on bioprocessing (Cytiva's bioreactors, membranes, single-use manufacturing for drug production), clinical diagnostics (Beckman Coulter chemistry and hematology analyzers, Radiometer blood gas analyzers, Cepheid molecular diagnostics), and life sciences research instruments (SCIEX mass spectrometry, Leica Microsystems microscopy).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.